Juan Pinilla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Juan Pinilla has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
Brijesh Baral
2 shared publications- Larissa Araújo de Lucena
Federal University of Rio Grande do Norte, Natal, Brazil
2 shared publications - Miguel Angel Samaniego Laguna
Universidad Autonoma Metropolitana, Mexico City, Mexico
2 shared publications - Mrunalini Dandamudi
Department of Cardiology, Charleston Area Medical Center, Charleston, WV, USA
2 shared publications - Nyree Nava
Universidad Autónoma Metropolitana Mexico City Mexico
2 shared publications - Sebastian Jaramillo
Universidad Austral Pilar Argentina
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 17 (9) , 529-536
Catastrophic Outcome of Pregnancy Complicated With Tricuspid Valve Nonbacterial Thrombotic Endocarditis
Nonbacterial thrombotic endocarditis (NBTE) is a rare condition characterized by sterile fibrin-platelet vegetations on cardiac valves, typically associated with hypercoagulable states. Isolated tricuspid valve (TV) involvement during pregnancy is exceedingly rare, with no previously reported cases of fatal maternal and fetal outcome in the published literature. We report a 31-year-old woman (gravida 3) with a complex medical history including human immunodeficiency virus infection, chronic kidney disease, recurrent venous thromboembolism, and thrombocytopenia, who presented at 9 weeks of gestation with a large, mobile TV mass. Initial workup revealed elevated IgM antiphospholipid antibodies, a positive dilute Russell’s viper venom time, negative blood cultures, and a concurrent pulmonary embolism. A transthoracic echocardiogram identified a 2.2 × 1.6 cm irregular hyperechoic mass on the anterior tricuspid leaflet. Despite therapeutic anticoagulation with enoxaparin and aspirin, the mass enlarged to 3.5 × 2.7 cm by 13 weeks of gestation. Following multidisciplinary discussion and shared decision-making with the patient, AngioVac-assisted percutaneous aspiration thrombectomy was performed at 14 weeks and 4 days of gestation. Histopathology confirmed sterile fibrin thrombi with histiocytic infiltration consistent with NBTE. Fetal demise was identified on postoperative day 2. Subsequently, the patient developed encephalopathy and massive hemoptysis, raising concern for catastrophic antiphospholipid syndrome. Despite aggressive resuscitation including venovenous extracorporeal membrane oxygenation, continuous renal replacement therapy, and maximum vasopressor support, the patient died. This is the first reported case of fatal maternal and fetal outcomes associated with TV NBTE during pregnancy. The case underscores the challenges of evaluation and management of cardiac masses in immunocompromised pregnant patients, the limitations of APS classification criteria in the peripartum setting, and the importance of a multidisciplinary cardio-obstetric approach.
- 1 September 2026
- Published by Elmer Press, Inc. in Journal of Medical Cases
- Vol. 17 (9) , 529-536
Open AccessCatastrophic Outcome of Pregnancy Complicated With Tricuspid Valve Nonbacterial Thrombotic Endocarditis
Nonbacterial thrombotic endocarditis (NBTE) is a rare condition characterized by sterile fibrin-platelet vegetations on cardiac valves, typically associated with hypercoagulable states. Isolated tricuspid valve (TV) involvement during pregnancy is exceedingly rare, with no previously reported cases of fatal maternal and fetal outcome in the published literature. We report a 31-year-old woman (gravida 3) with a complex medical history including human immunodeficiency virus infection, chronic kidney disease, recurrent venous thromboembolism, and thrombocytopenia, who presented at 9 weeks of gestation with a large, mobile TV mass. Initial workup revealed elevated IgM antiphospholipid antibodies, a positive dilute Russell’s viper venom time, negative blood cultures, and a concurrent pulmonary embolism. A transthoracic echocardiogram identified a 2.2 × 1.6 cm irregular hyperechoic mass on the anterior tricuspid leaflet. Despite therapeutic anticoagulation with enoxaparin and aspirin, the mass enlarged to 3.5 × 2.7 cm by 13 weeks of gestation. Following multidisciplinary discussion and shared decision-making with the patient, AngioVac-assisted percutaneous aspiration thrombectomy was performed at 14 weeks and 4 days of gestation. Histopathology confirmed sterile fibrin thrombi with histiocytic infiltration consistent with NBTE. Fetal demise was identified on postoperative day 2. Subsequently, the patient developed encephalopathy and massive hemoptysis, raising concern for catastrophic antiphospholipid syndrome. Despite aggressive resuscitation including venovenous extracorporeal membrane oxygenation, continuous renal replacement therapy, and maximum vasopressor support, the patient died. This is the first reported case of fatal maternal and fetal outcomes associated with TV NBTE during pregnancy. The case underscores the challenges of evaluation and management of cardiac masses in immunocompromised pregnant patients, the limitations of APS classification criteria in the peripartum setting, and the importance of a multidisciplinary cardio-obstetric approach.
- Open Access
- 26 August 2026
- Published by Elsevier in JACC: Advances
PPV23 Vaccination and Risk of Cardiovascular Events
- 26 August 2026
- Published by Elsevier in JACC: Advances
Open AccessPPV23 Vaccination and Risk of Cardiovascular Events
- 5 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (10) , 1845-1856
Intracardiac vs. transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: a systematic review and meta-analysis
Aims: Intracardiac echocardiography (ICE) is a valuable, real-time imaging tool in structural cardiology and electrophysiology, performed without general anaesthesia. However, its safety compared to transesophageal echocardiography (TEE) remains unclear. Objective: To conduct a meta-analysis evaluating outcomes of catheter ablation for atrial fibrillation (AF) with or without left atrial appendage closure (LAAC) guided by TEE vs. ICE. Methods and results: Databases were searched for studies comparing ICE with TEE guidance during AF ablation ± LAAC. Outcomes were pooled using the inverse-variance (IV) random-effects model in R, with risk ratios (RRs) for dichotomous variables and mean or standardized mean differences (MD or SMD) for continuous variables, and 95% confidence intervals (CIs) reported. We included eight studies involving 7671 patients, of whom 3903 (50.9%) underwent procedures with ICE guidance. There were no significant differences between groups in cardiac tamponade risk (RR 0.86; 95% CI 0.44–1.66; P = 0.39), stroke, or transient ischaemic attack (RR 1.00; 95% CI 0.39–2.55; P = 0.57), and vascular complications (RR 0.80; 95% CI 0.51–1.25; P = 0.37). ICE was associated with lower pre-procedure LAA thrombus detection (RR 0.32; 95% CI 0.11–0.94; P = 0.04), radiation dose (SMD −0.47; 95% CI −0.90 to −0.04; P = 0.03), and fluoroscopy time (−4.25 min; 95% CI −6.01 to −2.49; P < 0.01) but the procedure duration was significantly lower only in combined AF ablation + LAAC (MD −19.56 min; 95% CI −24.15 to −14.97; P < 0.01). Conclusion: This meta-analysis indicates that ICE is a safe, effective, and non-inferior alternative to TEE for patients undergoing AF ablation ± LAAC. However, TEE remains an effective tool for detecting LAA thrombus.
- 5 August 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (10) , 1845-1856
Intracardiac vs. transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: a systematic review and meta-analysis
Aims: Intracardiac echocardiography (ICE) is a valuable, real-time imaging tool in structural cardiology and electrophysiology, performed without general anaesthesia. However, its safety compared to transesophageal echocardiography (TEE) remains unclear. Objective: To conduct a meta-analysis evaluating outcomes of catheter ablation for atrial fibrillation (AF) with or without left atrial appendage closure (LAAC) guided by TEE vs. ICE. Methods and results: Databases were searched for studies comparing ICE with TEE guidance during AF ablation ± LAAC. Outcomes were pooled using the inverse-variance (IV) random-effects model in R, with risk ratios (RRs) for dichotomous variables and mean or standardized mean differences (MD or SMD) for continuous variables, and 95% confidence intervals (CIs) reported. We included eight studies involving 7671 patients, of whom 3903 (50.9%) underwent procedures with ICE guidance. There were no significant differences between groups in cardiac tamponade risk (RR 0.86; 95% CI 0.44–1.66; P = 0.39), stroke, or transient ischaemic attack (RR 1.00; 95% CI 0.39–2.55; P = 0.57), and vascular complications (RR 0.80; 95% CI 0.51–1.25; P = 0.37). ICE was associated with lower pre-procedure LAA thrombus detection (RR 0.32; 95% CI 0.11–0.94; P = 0.04), radiation dose (SMD −0.47; 95% CI −0.90 to −0.04; P = 0.03), and fluoroscopy time (−4.25 min; 95% CI −6.01 to −2.49; P < 0.01) but the procedure duration was significantly lower only in combined AF ablation + LAAC (MD −19.56 min; 95% CI −24.15 to −14.97; P < 0.01). Conclusion: This meta-analysis indicates that ICE is a safe, effective, and non-inferior alternative to TEE for patients undergoing AF ablation ± LAAC. However, TEE remains an effective tool for detecting LAA thrombus.
- 27 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 509-518
Infective endocarditis in patients with and without CHD: a meta-analysis of age-specific outcomes
Background: Infective endocarditis remains a serious condition. Patients with CHD are particularly susceptible due to structural abnormalities and repeated interventions. However, comparative data on infective endocarditis outcomes in patients with and without CHD stratified by age group remain limited. Methods: We searched PubMed, Embase, and Cochrane for cohort studies comparing infective endocarditis outcomes in CHD versus non-CHD. Risk ratios with 95% confidence intervals were pooled using random-effects models. Results: We included six observational cohort studies encompassing 180,194 patients, of whom 176,882 were adults and 3312 were children. Overall, 65% of the population were male. Patients with CHD tended to be younger and carried a lower comorbidity burden. CHD was associated with lower in-hospital mortality risk in adults (RR 0.42; 95% CI 0.34–0.53; p < 0.01), whereas children with CHD demonstrated higher risk (RR 1.59; 95% CI 1.08 to 2.32; p = 0.02). Streptococcus infective endocarditis was more common in adults with CHD (RR 1.28; 95% CI 1.09 to 1.50; p < 0.01), while Staphylococcus aureus infective endocarditis was less common in both adults (RR 0.71; 95% CI 0.58 to 0.88; p < 0.01) and paediatric (RR 0.73; 95% CI 0.64 to 0.84; p < 0.01) CHD patients. Conclusion: In this meta-analysis, mortality patterns in CHD varied by age, with lower mortality in adults and higher mortality in children. Streptococcus infective endocarditis was more common in adults with CHD, whereas Staphylococcus aureus was less frequent across CHD age groups. These results highlight the need for age-specific and individualised endocarditis management in CHD.
- 27 March 2026
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 36 (3) , 509-518
Infective endocarditis in patients with and without CHD: a meta-analysis of age-specific outcomes
Background: Infective endocarditis remains a serious condition. Patients with CHD are particularly susceptible due to structural abnormalities and repeated interventions. However, comparative data on infective endocarditis outcomes in patients with and without CHD stratified by age group remain limited. Methods: We searched PubMed, Embase, and Cochrane for cohort studies comparing infective endocarditis outcomes in CHD versus non-CHD. Risk ratios with 95% confidence intervals were pooled using random-effects models. Results: We included six observational cohort studies encompassing 180,194 patients, of whom 176,882 were adults and 3312 were children. Overall, 65% of the population were male. Patients with CHD tended to be younger and carried a lower comorbidity burden. CHD was associated with lower in-hospital mortality risk in adults (RR 0.42; 95% CI 0.34–0.53; p < 0.01), whereas children with CHD demonstrated higher risk (RR 1.59; 95% CI 1.08 to 2.32; p = 0.02). Streptococcus infective endocarditis was more common in adults with CHD (RR 1.28; 95% CI 1.09 to 1.50; p < 0.01), while Staphylococcus aureus infective endocarditis was less common in both adults (RR 0.71; 95% CI 0.58 to 0.88; p < 0.01) and paediatric (RR 0.73; 95% CI 0.64 to 0.84; p < 0.01) CHD patients. Conclusion: In this meta-analysis, mortality patterns in CHD varied by age, with lower mortality in adults and higher mortality in children. Streptococcus infective endocarditis was more common in adults with CHD, whereas Staphylococcus aureus was less frequent across CHD age groups. These results highlight the need for age-specific and individualised endocarditis management in CHD.
- 24 August 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (4) , 2675-2685
MitraClip Versus Surgery for Secondary Mitral Regurgitation: A Systematic Review and Updated Meta‐Analysis
Background: The optimal management of secondary mitral regurgitation (MR) remains uncertain, with surgical and percutaneous approaches offering alternative treatment strategies. Aim: To compare percutaneous repair with mitral transcatheter edge‐to‐edge repair (M‐TEER) using MitraClip and surgical intervention in patients with secondary MR. Methods: We systematically searched PubMed, Embase, and Cochrane for studies comparing M‐TEER using MitraClip with surgery in secondary MR, reporting outcomes of interest. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using a random‐effects model in R software. Heterogeneity was assessed with I² statistics. Results: A total of 11 studies (two randomized controlled trials and nine observational studies) comprising 1605 patients were included. The mean age was 69 years. Among them, 906 (57.7%) underwent MitraClip. Mean follow‐up was 24.7 months (minimum: 6 months). The rate of MR grade ≤ 2+ at follow‐up was lower in the MitraClip group compared to surgery (RR: 0.86, 95% CI: 0.78 to 0.95, p < 0.01). No significant differences were observed in all‐cause mortality (RR: 1.18, 95% CI: 0.93 to 1.49, p = 0.16), cardiovascular mortality (RR: 1.42, 95% CI: 0.54 to 3.68, p = 0.47), heart failure hospitalizations (RR: 1.55, 95% CI: 0.79 to 3.04, p = 0.20), or NYHA class I/II at follow‐up (RR: 0.92, 95% CI: 0.83 to 1.01, p = 0.08). Conclusion: Although patients undergoing MitraClip exhibited a lower rate of residual MR ≤ 2+ at follow‐up compared to those treated surgically, this did not translate into higher rates of clinical outcomes, including all‐cause mortality, cardiovascular mortality, heart failure hospitalizations, or impaired functional status (NYHA classification).
- 24 August 2025
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 106 (4) , 2675-2685
MitraClip Versus Surgery for Secondary Mitral Regurgitation: A Systematic Review and Updated Meta‐Analysis
Background: The optimal management of secondary mitral regurgitation (MR) remains uncertain, with surgical and percutaneous approaches offering alternative treatment strategies. Aim: To compare percutaneous repair with mitral transcatheter edge‐to‐edge repair (M‐TEER) using MitraClip and surgical intervention in patients with secondary MR. Methods: We systematically searched PubMed, Embase, and Cochrane for studies comparing M‐TEER using MitraClip with surgery in secondary MR, reporting outcomes of interest. Risk ratios (RR) with 95% confidence intervals (CI) were pooled using a random‐effects model in R software. Heterogeneity was assessed with I² statistics. Results: A total of 11 studies (two randomized controlled trials and nine observational studies) comprising 1605 patients were included. The mean age was 69 years. Among them, 906 (57.7%) underwent MitraClip. Mean follow‐up was 24.7 months (minimum: 6 months). The rate of MR grade ≤ 2+ at follow‐up was lower in the MitraClip group compared to surgery (RR: 0.86, 95% CI: 0.78 to 0.95, p < 0.01). No significant differences were observed in all‐cause mortality (RR: 1.18, 95% CI: 0.93 to 1.49, p = 0.16), cardiovascular mortality (RR: 1.42, 95% CI: 0.54 to 3.68, p = 0.47), heart failure hospitalizations (RR: 1.55, 95% CI: 0.79 to 3.04, p = 0.20), or NYHA class I/II at follow‐up (RR: 0.92, 95% CI: 0.83 to 1.01, p = 0.08). Conclusion: Although patients undergoing MitraClip exhibited a lower rate of residual MR ≤ 2+ at follow‐up compared to those treated surgically, this did not translate into higher rates of clinical outcomes, including all‐cause mortality, cardiovascular mortality, heart failure hospitalizations, or impaired functional status (NYHA classification).
- 18 August 2025
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 33 (6) , e574-e576
Intravenous Iron Therapy in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
- 18 August 2025
- Published by Wolters Kluwer Health in American Journal of Therapeutics
- Vol. 33 (6) , e574-e576
Intravenous Iron Therapy in Patients With Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis